Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age
NCT ID: NCT05745272
Last Updated: 2024-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1000 participants
OBSERVATIONAL
2023-12-11
2023-12-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors in Young Middle Eastern Women With Cardiovascular Disease
NCT04975503
Cardiovascular Patients With no Standard Modifiable Risk Factors
NCT06199869
Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
NCT00037258
Diet-induced Elevations in LDL-C and Progression of Atherosclerosis
NCT05733325
Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers
NCT03038750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Contemporary studies that evaluated levels of cardiovascular risk and LDL-C goal attainment in the Middle East are scarce. A prior study (CEPHEUS LEVANT) in the Middle East demonstrated that about 1 in 4 high-risk patients reach LDL-C goals.
The current study aims at studying cardiovascular risk categories according to the 2019 ESC/EAS and 2018 ACC/AHA Guidelines, and the attainment of LDL-C treatment goals in consecutive individuals aged 18-55 years who are evaluated in tertiary care centers as inpatients or in ambulatory care settings. The above age bracket was chosen because these are the individuals most prone to acute cardiovascular events with a high prevalence of diabetes mellitus and cigarette smoking.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals can give a history of the presence or absence of ASCVD and its risk factors
Exclusion Criteria
* Refusal of inability to give history on ASCVD and its risk factors
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cardiovascular Academy Group of the JCS
UNKNOWN
The Jordan Cardiac Society (JCS)
UNKNOWN
Istishari Hospital Department of Clinical Research
UNKNOWN
Jordan Collaborating Cardiology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Imad A. Alhaddad, MD FACC
Role: STUDY_CHAIR
Department of Cardiology, Jordan Hospital, Amman, Jordan
Ramzi Tabbalat
Role: STUDY_DIRECTOR
Cardiology Department, Abdali Hospital
Ayman Hammoudeh, MD FACC
Role: PRINCIPAL_INVESTIGATOR
Department of Clinical Research, Istishari Hospital, Aman, Jordan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istishari Hospital
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVA-G/JCS-1/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.